Intelligence / B2B SaaS / Acquisitions / Apogee Therapeutics, Inc.
M&Awas acquired (SEC 8-K)3 Sept 2026
Apogee Therapeutics, Inc.
3 Sept 2026: Was acquired (SEC 8-K) · Pharma and biotech. Recorded in the SEC EDGAR full-text search.
- Filed
- 3 Sept 2026
- Ticker
- APGE
- Role
- Was acquired
- Sector
- Pharma and biotech
- Sic
- 2836
- Items
- 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
- Summary
- As previously disclosed, on June 18, 2026, Apogee Therapeutics, Inc., a Delaware corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Andor LLC, a Delaware limited liability company and a wholly owned subsidiary of Guarantor ("Parent"), Andor Merger Co., a Delaware corp
- Location
- San Francisco, CA
- State
- California
- Country
- United States
- SEC CIK
- 1974640
- Reference
- 0001140361-26-035537
What this signal means
Integration means consolidating tools and vendors: the buyer re-platforms the target, and an acquired company's stack is reviewed by its new owner.
- Completed an acquisition leads with 189 of 292, then Sold assets or a business (82).
- 103 added in the 30 days to 19 Nov 2026.
Reach them with AOS
Find the decision makers at Apogee Therapeutics, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this m&a signal, for your approval.
More in Was acquired
Acquisitions
18 NovImpact Biomedical INC.was acquired (SEC 8-K) · Pharma and biotechM&A6 NovBowman Consulting Group Ltd.was acquired (SEC 8-K) · Business servicesM&A2 NovKenvue Inc.was acquired (SEC 8-K) · ManufacturingM&A2 NovLiveRamp Holdings, Inc.was acquired (SEC 8-K) · Software and ITM&A2 NovSupernus Pharmaceuticals, INC.was acquired (SEC 8-K) · Pharma and biotechM&A26 OctNathans Famous, INC.was acquired (SEC 8-K) · Wholesale and retailM&A
Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 2.01 (completion of an acquisition or disposition of assets) filed with the SEC in the last 90 days. The role (buyer, company acquired, seller) is read from the filing's own wording, which is quoted on each row. AOS shows what the public record says; it does not verify or endorse the company.